Edward P. Evans Foundation funding opportunities that may be of interest to University of Illinois Cancer Center members.
EvansMDS Young Investigator Award 2025
- Full Proposal Deadline: 01/31/25
- Purpose: The Edward P. Evans Foundation seeks applications for its 2025 EvansMDS Young Investigator Award (“EYIA”) program to help develop the next generation of research leaders who will blaze a path toward finding therapies and cures for myelodysplastic syndrome (MDS). The ideal candidate will be a late-stage postdoctoral fellow with an established publication record of high impact research who is on track to obtaining a tenured position in the next year. Grants are up to $150,000 per year over 3 years ($450,000 total, including up to 8% in indirect costs), with year 2 and 3 funding conditional upon compliance with grant terms and progress towards independence.
- Letter of Intent: 01/31/25
- Full Proposal Deadline: Early April 2025 (TBD)
- Purpose: The EvansMDS Initiative seeks to fund research projects focusing on the etiology, pathogenesis, and treatment of myelodysplastic syndrome (MDS). Priority will be given to projects that directly examine key features of MDS rather than general concepts in leukemia, hematopoiesis, aging or immunology. Topics of interest include but are not limited to: 1) Longitudinal testable, extensible models of disease based upon patient data, covering all, or a portion of, the progression from clonal hematopoiesis to AML; 2) Analysis of the progression of clonal hematopoiesis to MDS and on to AML, and strategies to intervene, or prevent the pathogenesis of progression, particularly at earlier disease stages prior to MDS; 3) Development of preclinical models for the practical discovery and development of new MDS therapies; 4) Research to better understand germline mutations predisposing patients to MDS, age-associated clonal hematopoiesis or genetic mosaicism; 5) Large scale screening and molecular modeling against existing targets for the development of new MDS therapies; 6) Studies on improving the applicability or outcome of novel cell-based therapies or bone marrow transplants; 7) Correlative research to better understand, direct, or clarify the impact of clinical studies showing significant promise for the treatment of MDS; 8) Creating novel curated data sources for the application of machine learning to MDS analyses; 9) Novel imaging modalities and algorithms for improving diagnosis, understanding pathogenesis, and directing therapy. Grants are $250,000 per year for up to three years ($750,000 total).
The University of Illinois Cancer Center has approval to pursue the following grant opportunities from private funders through its Advancement team. As a Cancer Center member, please notify and work with Jane Erb ([email protected]) and her Advancement team if you have an interest in any of the following current opportunities or would like further information. The Advancement team will provide grant development support and handle submissions as awards count toward the Cancer Center’s philanthropic goals.